SI
ARKG icon

Stephens Inc’s ARK Genomic Revolution ETF ARKG Stock Holding History

Stephens Inc’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,432
Closed -$290K – 1307
2025
Q3 		$290K Buy
+10,432
New +$264K ﹤0.01% 1061
2024
Q2 		– Sell
-8,136
Closed -$234K – 1275
2024
Q1 		$234K Sell
8,136
-276
-3% -$8.3K ﹤0.01% 1098
2023
Q4 		$276K Buy
8,412
+35
+0.4% +$952 ﹤0.01% 964
2023
Q3 		$233K Sell
8,377
-457
-5% -$14.9K ﹤0.01% 984
2023
Q2 		$301K Sell
8,834
-299
-3% -$9.4K 0.01% 911
2023
Q1 		$275K Buy
9,133
+128
+1% +$3.97K 0.01% 914
2022
Q4 		$254K Sell
9,005
-698
-7% -$22.2K 0.01% 912
2022
Q3 		$319K Buy
9,703
+294
+3% +$10.8K 0.01% 872
2022
Q2 		$296K Sell
9,409
-547
-5% -$19.1K 0.01% 922
2022
Q1 		$457K Sell
9,956
-4,312
-30% -$206K 0.01% 848
2021
Q4 		$874K Buy
14,268
+378
+3% +$26.1K 0.01% 669
2021
Q3 		$1.04M Buy
13,890
+205
+1% +$17.2K 0.02% 641
2021
Q2 		$1.27M Buy
13,685
+1,857
+16% +$158K 0.02% 594
2021
Q1 		$1.05M Sell
11,828
-37,191
-76% -$3.69M 0.02% 606
2020
Q4 		$4.57M Sell
49,019
-6,405
-12% -$510K 0.08% 256
2020
Q3 		$3.53M Sell
55,424
-5,028
-8% -$295K 0.07% 272
2020
Q2 		$3.15M Buy
+60,452
New +$2.59M 0.07% 283
2020
Q1 		– Sell
-7,372
Closed -$247K – 1110
2019
Q4 		$247K Sell
7,372
-5,150
-41% -$164K 0.01% 943
2019
Q3 		$370K Sell
12,522
-99,120
-89% -$3.22M 0.01% 840
2019
Q2 		$3.85M Buy
111,642
+92,306
+477% +$2.96M 0.09% 258
2019
Q1 		$636K Sell
19,336
-68,866
-78% -$2.03M 0.02% 691
2018
Q4 		$2.12M Sell
88,202
-15,563
-15% -$439K 0.06% 340
2018
Q3 		$3.47M Buy
+103,765
New +$3.28M 0.09% 287

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Stephens Inc's ARKG Position: Q4 2025 in Review

Stephens Inc sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 10,432 shares — an estimated $290K sold.

Stephens Inc first reported a position in ARKG in Q3 2018 and held it in 23 quarters. The position peaked at $4.57M in Q4 2020. 239 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

  • Stephens Inc reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
  • Stephens Inc sold 10,432 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $290K.
  • Stephens Inc first reported a position in ARK Genomic Revolution ETF in Q3 2018 and held it in 23 quarters.
  • Stephens Inc's ARK Genomic Revolution ETF position peaked at $4.57M in Q4 2020.
  • 239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Stephens Inc's 13F filing for Q4 2025, filed 5 Feb 2026.